{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:00:18Z","timestamp":1784228418075,"version":"3.55.0"},"reference-count":105,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01DA05726701"],"award-info":[{"award-number":["R01DA05726701"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>In the United States, there has been a concerning rise in the prevalence of opioid use disorders (OUD) among transition-age (TA) adults, 18 to 25-years old, with a disproportionate impact on individuals and families covered by Medicaid. Of equal concern, the treatment system continues to underperform for many young people, emphasizing the need to address the treatment challenges faced by this vulnerable population at a pivotal juncture in their life course. Pharmacotherapy is the most effective treatment for OUD, yet notably, observational studies reveal gaps in the receipt of and retention in medications for opioid use disorder (MOUD), resulting in poor outcomes for many TA adults in treatment. Few current studies on OUD treatment quality explicitly consider the influence of individual, organizational, and contextual factors, especially for young people whose social roles and institutional ties remain in flux.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We introduce a retrospective, longitudinal cohort design to study treatment quality practices and outcomes among approximately 65,000 TA adults entering treatment for OUD between 2012 and 2025 in New York. We propose to combine data from multiple sources, including Medicaid claims and encounter data and a state registry of substance use disorder (SUD) treatment episodes, to examine three aspects of OUD treatment quality: 1) MOUD use, including MOUD option (e.g., buprenorphine, methadone, or extended-release [XR] naltrexone); 2) adherence to pharmacotherapy and retention in treatment; and 3) adverse events (e.g., overdoses). Using rigorous analytical methods, we will provide insights into how variation in treatment practices and outcomes are structured more broadly by multilevel processes related to communities, treatment programs, and characteristics of the patient, as well as their complex interplay.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Discussion<\/jats:title>\n<jats:p>Our findings will inform clinical decision making by patients and providers as well as public health responses to the rising number of young adults seeking treatment for OUD amidst the opioid and polysubstance overdose crisis in the U.S.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0297567","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T17:27:53Z","timestamp":1723656473000},"page":"e0297567","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lost in transition: A protocol for a retrospective, longitudinal cohort study for addressing challenges in opioid treatment for transition-age adults"],"prefix":"10.1371","volume":"19","author":[{"given":"Josh","family":"Aleksanyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sugy","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Lincourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly S.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5025-893X","authenticated-orcid":true,"given":"Shazia","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9426-2869","authenticated-orcid":true,"given":"Ashly E.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"D\u2019Aunno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Glied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McNeely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1615-9430","authenticated-orcid":true,"given":"Brian","family":"Elbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tod","family":"Mijanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samrachana","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Neighbors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"pone.0297567.ref001","author":"D. Smith","year":"2018","journal-title":"Emerging Adults and Substance Use Disorder Treatment: Oxford"},{"key":"pone.0297567.ref002","unstructured":"Institute of Medicine, National Research Council. In: Bonnie RJ, Stroud C, Breiner H, editors. Investing in the Health and Well-Being of Young Adults. Washington (DC)2015."},{"issue":"5","key":"pone.0297567.ref003","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0003-066X.55.5.469","article-title":"Emerging adulthood. A theory of development from the late teens through the twenties","volume":"55","author":"JJ Arnett","year":"2000","journal-title":"Am Psychol"},{"issue":"Suppl 2","key":"pone.0297567.ref004","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1542\/peds.2020-023523B","article-title":"Principles of Care for Young Adults With Substance Use Disorders","volume":"147","author":"M Silverstein","year":"2021","journal-title":"Pediatrics"},{"key":"pone.0297567.ref005","first-page":"277","author":"DC Smith","year":"2018"},{"key":"pone.0297567.ref006","volume-title":"Investing in the Health and Well-Being of Young Adults.","author":"National Research Council","year":"2015"},{"key":"pone.0297567.ref007","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. Rockville, MD; 2020. Contract No.: HHS Pub No PEP20-07-01-001, NSDUH Series H-55."},{"issue":"6","key":"pone.0297567.ref008","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1176\/appi.ajp.160.6.1041","article-title":"Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability.","volume":"160","author":"RA Chambers","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"1","key":"pone.0297567.ref009","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13011-020-00300-7","article-title":"Individualized approach to primary prevention of substance use disorder: age-related risks.","volume":"15","author":"E Afuseh","year":"2020","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"2","key":"pone.0297567.ref010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0163278714521812","article-title":"Emerging Adulthood: Developmental Period Facilitative of the Addictions.","volume":"37","author":"S Sussman","year":"2014","journal-title":"Eval Health Prof."},{"key":"pone.0297567.ref011","article-title":"Commentary: Substance use and the brain: it is not straightforward to differentiate cause from consequence\u2014a commentary on Kim-Spoon et al. (2020).","author":"S. Wilson","year":"2020","journal-title":"J Child Psychol Psychiatry."},{"key":"pone.0297567.ref012","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.dcn.2015.12.010","article-title":"The dual systems model: Review, reappraisal, and reaffirmation.","volume":"17","author":"EP Shulman","year":"2016","journal-title":"Dev Cogn Neurosci"},{"key":"pone.0297567.ref013","author":"General OotS","year":"2016"},{"issue":"25","key":"pone.0297567.ref014","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1056\/NEJMp1612578","article-title":"Ending the Opioid Epidemic\u2014A Call to Action","volume":"375","author":"VH Murthy","year":"2016","journal-title":"N Engl J Med"},{"key":"pone.0297567.ref015","volume-title":"The President\u2019s Commission on Combating Drug Addiction and the Opioid Crisis Final Report","author":"C Christie","year":"2017"},{"issue":"13","key":"pone.0297567.ref016","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"AT McLellan","year":"2000","journal-title":"Jama"},{"issue":"1","key":"pone.0297567.ref017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","article-title":"Development of a Cascade of Care for responding to the opioid epidemic","volume":"45","author":"AR Williams","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"5","key":"pone.0297567.ref018","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1377\/hlthaff.2019.01085","article-title":"Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid.","volume":"39","author":"H Samples","year":"2020","journal-title":"Health Aff (Millwood)."},{"issue":"2","key":"pone.0297567.ref019","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1176\/appi.ajp.2019.19060612","article-title":"Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder.","volume":"177","author":"AR Williams","year":"2020","journal-title":"Am J Psychiatry."},{"key":"pone.0297567.ref020","doi-asserted-by":"crossref","first-page":"108329","DOI":"10.1016\/j.jsat.2021.108329","article-title":"Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings.","volume":"126","author":"N Krawczyk","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"pone.0297567.ref021","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/HRP.0000000000000052","article-title":"Long-term course of opioid addiction.","volume":"23","author":"YI Hser","year":"2015","journal-title":"Harv Rev Psychiatry"},{"issue":"11","key":"pone.0297567.ref022","doi-asserted-by":"crossref","first-page":"e1002969","DOI":"10.1371\/journal.pmed.1002969","article-title":"Stigma as a fundamental hindrance to the United States opioid overdose crisis response.","volume":"16","author":"AC Tsai","year":"2019","journal-title":"PLOS Medicine."},{"issue":"6408","key":"pone.0297567.ref023","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016","volume":"361","author":"H Jalal","year":"2018","journal-title":"Science"},{"issue":"26","key":"pone.0297567.ref024","first-page":"719","article-title":"Vital Signs: Demographic and Substance Use Trends Among Heroin Users\u2014United States, 2002\u20132013.","volume":"64","author":"CM Jones","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"pone.0297567.ref025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.drugalcdep.2018.03.056","article-title":"Predictors of transitions across stages of heroin use and dependence prior to treatment-seeking among people in treatment for opioid dependence","volume":"191","author":"B Larance","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"pone.0297567.ref026","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jadohealth.2020.09.020","article-title":"The Broken Care Continuum for Young Adults With Opioid Addiction.","volume":"67","author":"SE Hadland","year":"2020","journal-title":"J Adolesc Health."},{"issue":"6","key":"pone.0297567.ref027","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jadohealth.2020.07.038","article-title":"Young Adults Have Worse Outcomes Than Older Adults: Secondary Analysis of a Medication Trial for Opioid Use Disorder.","volume":"67","author":"M Fishman","year":"2020","journal-title":"J Adolesc Health."},{"key":"pone.0297567.ref028","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.drugalcdep.2014.07.023","article-title":"Do young people benefit from AA as much, and in the same ways, as adult aged 30+? A moderated multiple mediation analysis","volume":"143","author":"BB Hoeppner","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"pone.0297567.ref029","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.","volume":"9","author":"K Kampman","year":"2015","journal-title":"J Addict Med."},{"issue":"3","key":"pone.0297567.ref030","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1893","article-title":"Medication-Assisted Treatment of Adolescents With Opioid Use Disorders","volume":"138","author":"Committee On Substance USE, Prevention","year":"2016","journal-title":"Pediatrics"},{"key":"pone.0297567.ref031","author":"S Pietras","year":"2015"},{"key":"pone.0297567.ref032","volume-title":"Treatment Improvement Protocol (TIP) 63.","author":"Substance Abuse and Mental Health Services Administration.","year":"2020"},{"issue":"1","key":"pone.0297567.ref033","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13011-019-0215-4","article-title":"Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.","volume":"14","author":"CJ Neighbors","year":"2019","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"pone.0297567.ref034","article-title":"Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder","author":"SE Hadland","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"8","key":"pone.0297567.ref035","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamapediatrics.2017.0745","article-title":"Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001\u20132014","volume":"171","author":"SE Hadland","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"6","key":"pone.0297567.ref036","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jadohealth.2016.12.023","article-title":"Medication-Assisted Treatment for Adolescents in Specialty Treatment for Opioid Use Disorder.","volume":"60","author":"KA Feder","year":"2017","journal-title":"J Adolesc Health."},{"issue":"17","key":"pone.0297567.ref037","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial","volume":"300","author":"GE Woody","year":"2008","journal-title":"JAMA"},{"issue":"8","key":"pone.0297567.ref038","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/add.13363","article-title":"A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults.","volume":"111","author":"LA Marsch","year":"2016","journal-title":"Addiction"},{"issue":"5","key":"pone.0297567.ref039","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1360-0443.2003.00354.x","article-title":"Does retention matter? Treatment duration and improvement in drug use.","volume":"98","author":"Z Zhang","year":"2003","journal-title":"Addiction"},{"issue":"3","key":"pone.0297567.ref040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0740-5472(03)00130-2","article-title":"Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS).","volume":"25","author":"RL Hubbard","year":"2003","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"pone.0297567.ref041","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1360-0443.2003.00327.x","article-title":"Long-term influence of duration and intensity of treatment on previously untreated individuals with alcohol use disorders","volume":"98","author":"RH Moos","year":"2003","journal-title":"Addiction"},{"issue":"2","key":"pone.0297567.ref042","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0376-8716(99)00082-4","article-title":"Patient histories, retention, and outcome models for younger and older adults in DATOS.","volume":"57","author":"CE Grella","year":"1999","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"pone.0297567.ref043","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1360-0443.2004.00831.x","article-title":"Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program","volume":"99","author":"DD Satre","year":"2004","journal-title":"Addiction"},{"issue":"1","key":"pone.0297567.ref044","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review.","volume":"35","author":"C Timko","year":"2016","journal-title":"J Addict Dis"},{"issue":"6","key":"pone.0297567.ref045","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/0193841X07307315","article-title":"Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up study.","volume":"31","author":"YI Hser","year":"2007","journal-title":"Eval Rev."},{"issue":"7","key":"pone.0297567.ref046","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/aje\/kws284","article-title":"Characterizing durations of heroin abstinence in the California Civil Addict Program: results from a 33-year observational cohort study","volume":"177","author":"B Nosyk","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"3","key":"pone.0297567.ref047","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.","author":"RP Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"issue":"12","key":"pone.0297567.ref048","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.","volume":"68","author":"RD Weiss","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"1\u20133","key":"pone.0297567.ref049","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2007.11.021","article-title":"A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification","volume":"94","author":"VA Gruber","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"pone.0297567.ref050","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.283.10.1303","article-title":"Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial","volume":"283","author":"KL Sees","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"pone.0297567.ref051","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/ADM.0000000000000035","article-title":"A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine\/naloxone clinic.","volume":"8","author":"SC Matson","year":"2014","journal-title":"J Addict Med"},{"issue":"1","key":"pone.0297567.ref052","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12887-018-1137-4","article-title":"Opioid substitution treatment and heroin dependent adolescents: reductions in heroin use and treatment retention over twelve months","volume":"18","author":"BP Smyth","year":"2018","journal-title":"BMC Pediatr"},{"key":"pone.0297567.ref053","doi-asserted-by":"crossref","first-page":"108028","DOI":"10.1016\/j.jsat.2020.108028","article-title":"Medication for opioid use disorder treatment and specialty outpatient substance use treatment outcomes: Differences in retention and completion among opioid-related discharges in 2016.","volume":"114","author":"MS Askari","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"pone.0297567.ref054","doi-asserted-by":"crossref","first-page":"108130","DOI":"10.1016\/j.drugalcdep.2020.108130","article-title":"Age disparities in six-month treatment retention for opioid use disorder","volume":"213","author":"CM Mintz","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"pone.0297567.ref055","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cpr.2013.07.007","article-title":"Drop-out from addiction treatment: a systematic review of risk factors.","volume":"33","author":"HH Brorson","year":"2013","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"pone.0297567.ref056","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jsat.2014.04.006","article-title":"Emerging adult age status predicts poor buprenorphine treatment retention.","volume":"47","author":"Z Schuman-Olivier","year":"2014","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"pone.0297567.ref057","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/epirev\/mxaa001","article-title":"Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults.","volume":"42","author":"A Viera","year":"2020","journal-title":"Epidemiol Rev."},{"issue":"1","key":"pone.0297567.ref058","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jadohealth.2022.08.026","article-title":"Ambivalence and Stigma Beliefs About Medication Treatment Among Young Adults With Opioid Use Disorder: A Qualitative Exploration of Young Adults\u2019 Perspectives.","volume":"72","author":"SM Bagley","year":"2023","journal-title":"Journal of Adolescent Health"},{"issue":"3","key":"pone.0297567.ref059","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1037\/adb0000267","article-title":"Substance use prevention and treatment outcomes for emerging adults in non-college settings: A meta-analysis.","volume":"31","author":"JP Davis","year":"2017","journal-title":"Psychol Addict Behav"},{"issue":"3","key":"pone.0297567.ref060","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/ADM.0000000000000388","article-title":"Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review.","volume":"12","author":"JT Borodovsky","year":"2018","journal-title":"J Addict Med."},{"issue":"3","key":"pone.0297567.ref061","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/08964280009595760","article-title":"Social ecology and behavioral medicine: implications for training, practice, and policy.","volume":"26","author":"D. Stokols","year":"2000","journal-title":"Behav Med."},{"issue":"1","key":"pone.0297567.ref062","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1037\/0003-066X.47.1.6","article-title":"Establishing and maintaining healthy environments. Toward a social ecology of health promotion","volume":"47","author":"D Stokols","year":"1992","journal-title":"Am Psychol"},{"key":"pone.0297567.ref063","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2307\/2626958","article-title":"Social conditions as fundamental causes of disease","author":"BG Link","year":"1995","journal-title":"Journal of health and social behavior"},{"issue":"3","key":"pone.0297567.ref064","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/add.15181","article-title":"A pilot randomized controlled trial of assertive treatment including family involvement and home delivery of medication for young adults with opioid use disorder.","volume":"116","author":"M Fishman","year":"2021","journal-title":"Addiction"},{"issue":"Suppl 2","key":"pone.0297567.ref065","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1542\/peds.2020-023523D","article-title":"Evidence-Based Treatment of Young Adults With Substance Use Disorders","volume":"147","author":"SE Hadland","year":"2021","journal-title":"Pediatrics"},{"issue":"Suppl 2","key":"pone.0297567.ref066","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1542\/peds.2020-023523C","article-title":"Engaging the Family in the Care of Young Adults With Substance Use Disorders","volume":"147","author":"SM Bagley","year":"2021","journal-title":"Pediatrics"},{"issue":"1","key":"pone.0297567.ref067","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13011-020-00284-4","article-title":"Barriers, facilitators, and disparities in retention for adolescents in treatment for substance use disorders: a qualitative study with treatment providers.","volume":"15","author":"A Acevedo","year":"2020","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"Suppl 2","key":"pone.0297567.ref068","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1542\/peds.2020-023523H","article-title":"The Justice System and Young Adults With Substance Use Disorders","volume":"147","author":"S Siringil Perker","year":"2021","journal-title":"Pediatrics"},{"issue":"11","key":"pone.0297567.ref069","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1177\/1049732316679372","article-title":"Initiation of Addiction Treatment and Access to Services: Young Adults\u2019 Accounts of Their Help-Seeking Experiences.","volume":"27","author":"V Wagner","year":"2017","journal-title":"Qual Health Res."},{"issue":"5","key":"pone.0297567.ref070","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jsat.2012.10.004","article-title":"Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes","volume":"44","author":"H Matusow","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"pone.0297567.ref071","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1300\/J126v02n04_07","article-title":"Trading one drug for another? What drug treatment court professionals need to learn about opioid replacement therapy","volume":"2","author":"PF Hora","year":"2005","journal-title":"Journal of Maintenance in the Addictions"},{"issue":"1","key":"pone.0297567.ref072","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.","volume":"33","author":"PD Friedmann","year":"2012","journal-title":"Substance Abuse"},{"key":"pone.0297567.ref073","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsat.2014.10.001","article-title":"Effect of an Organizational Linkage Intervention on Staff Perceptions of Medication-Assisted Treatment and Referral Intentions in Community Corrections","volume":"50","author":"PD Friedmann","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"pone.0297567.ref074","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/ADM.0000000000000164","article-title":"Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program.","volume":"9","author":"AJ Gordon","year":"2015","journal-title":"J Addict Med."},{"key":"pone.0297567.ref075","doi-asserted-by":"crossref","first-page":"948789","DOI":"10.1155\/2011\/948789","article-title":"Distance traveled and cross-state commuting to opioid treatment programs in the United States.","volume":"2011","author":"A Rosenblum","year":"2011","journal-title":"J Environ Public Health"},{"issue":"1\u20133","key":"pone.0297567.ref076","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2011.10.016","article-title":"The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone","volume":"123","author":"BD Stein","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"pone.0297567.ref077","doi-asserted-by":"crossref","first-page":"108159","DOI":"10.1016\/j.jsat.2020.108159","article-title":"Youth OUD treatment during and after COVID: Increasing family involvement across the services continuum.","volume":"120","author":"A Hogue","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"pone.0297567.ref078","first-page":"248","author":"EH Bradley","year":"2013","edition":"1"},{"issue":"3","key":"pone.0297567.ref079","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City.","volume":"40","author":"HB Hansen","year":"2013","journal-title":"J Behav Health Serv Res"},{"issue":"9","key":"pone.0297567.ref080","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.clinthera.2019.07.019","article-title":"Personal and Socioeconomic Determinants in Medication-assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.","volume":"41","author":"LK Grubb","year":"2019","journal-title":"Clin Ther."},{"issue":"11","key":"pone.0297567.ref081","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1176\/ps.62.11.pss6211_1273","article-title":"Racial-ethnic disparities in substance abuse treatment: the role of criminal history and socioeconomic status.","volume":"62","author":"BL Cook","year":"2011","journal-title":"Psychiatr Serv"},{"issue":"1","key":"pone.0297567.ref082","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaac.2010.10.005","article-title":"Disparities in treatment for substance use disorders and co-occurring disorders for ethnic\/racial minority youth.","volume":"50","author":"M Alegria","year":"2011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"pone.0297567.ref083","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2018.06.006","article-title":"Treatment outcome disparities for opioid users: Are there racial and ethnic differences in treatment completion across large US metropolitan areas?","volume":"190","author":"GJ Stahler","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"pone.0297567.ref084","doi-asserted-by":"crossref","first-page":"108087","DOI":"10.1016\/j.drugalcdep.2020.108087","article-title":"Substance use improvement depends on Race\/Ethnicity: Outpatient treatment disparities observed in a large US national sample","volume":"213","author":"E Sahker","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"pone.0297567.ref085","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11414-020-09703-7","article-title":"Incarceration as a Reason for US Alcohol and Drug Treatment Non-completion: a Multilevel Analysis of Racial\/Ethnic and Sex Disparities","volume":"47","author":"G Pro","year":"2020","journal-title":"J Behav Health Serv Res"},{"issue":"Suppl 2","key":"pone.0297567.ref086","doi-asserted-by":"crossref","first-page":"S268","DOI":"10.1542\/peds.2020-023523L","article-title":"Addressing Racial Trauma in the Treatment of Substance Use Disorders","volume":"147","author":"M Komaromy","year":"2021","journal-title":"Pediatrics"},{"issue":"3","key":"pone.0297567.ref087","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsat.2006.06.016","article-title":"The role of organization and management in substance abuse treatment: Review and roadmap","volume":"31","author":"T. D\u2019Aunno","year":"2006","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"pone.0297567.ref088","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.addbeh.2011.01.032","article-title":"Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.","volume":"36","author":"PM Roman","year":"2011","journal-title":"Addict Behav"},{"issue":"4","key":"pone.0297567.ref089","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.evalprogplan.2011.02.004","article-title":"Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure.","volume":"34","author":"HK Knudsen","year":"2011","journal-title":"Eval Program Plann."},{"key":"pone.0297567.ref090","volume-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences E, Medicine","year":"2019"},{"issue":"1","key":"pone.0297567.ref091","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11469-012-9402-5","article-title":"Drug Addiction Stigma in the Context of Methadone Maintenance Therapy: An Investigation into Understudied Sources of Stigma.","volume":"11","author":"V Earnshaw","year":"2013","journal-title":"International Journal of Mental Health and Addiction"},{"issue":"4","key":"pone.0297567.ref092","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jadohealth.2020.03.005","article-title":"Adolescent-Serving Addiction Treatment Facilities in the United States and the Availability of Medications for Opioid Use Disorder","volume":"67","author":"RH Alinsky","year":"2020","journal-title":"Journal of Adolescent Health"},{"issue":"10051","key":"pone.0297567.ref093","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(16)31573-2","article-title":"How the paediatric workforce can address the opioid crisis","volume":"388","author":"SE Hadland","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"pone.0297567.ref094","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/08897077.2019.1635969","article-title":"Retention in care as a quality measure for opioid use disorder.","volume":"40","author":"SA Martin","year":"2019","journal-title":"Subst Abus."},{"key":"pone.0297567.ref095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jsat.2015.05.001","article-title":"Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.","volume":"57","author":"RE Clark","year":"2015","journal-title":"J Subst Abuse Treat."},{"issue":"2","key":"pone.0297567.ref096","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/1468-0009.12189","article-title":"\"Evaluating the Quality of Medical Care\": Donabedian\u2019s Classic Article 50 Years Later.","volume":"94","author":"D Berwick","year":"2016","journal-title":"Milbank Q."},{"issue":"12","key":"pone.0297567.ref097","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1988.03410120089033","article-title":"The quality of care. How can it be assessed?","volume":"260","author":"A. Donabedian","year":"1988","journal-title":"JAMA"},{"issue":"1","key":"pone.0297567.ref098","first-page":"173","article-title":"Quality assessment and assurance: unity of purpose, diversity of means","volume":"25","author":"A. Donabedian","year":"1988","journal-title":"Inquiry"},{"key":"pone.0297567.ref099","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/978-1-4419-6646-9","volume-title":"Survival Analysis: A Self-Learning Text","author":"DG Kleinbaum","year":"2012","edition":"3"},{"issue":"4","key":"pone.0297567.ref100","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.0006-341X.2000.01016.x","article-title":"Estimation of multivariate frailty models using penalized partial likelihood","volume":"56","author":"S Ripatti","year":"2000","journal-title":"Biometrics"},{"key":"pone.0297567.ref101","volume-title":"The Logic of Scientific Discovery","author":"K. Popper","year":"1959"},{"key":"pone.0297567.ref102","first-page":"623","volume-title":"Experimental and Quasi-Experimental Designs for Generalized Causal Inference","author":"WR Shadish","year":"2002"},{"key":"pone.0297567.ref103","doi-asserted-by":"crossref","first-page":"108666","DOI":"10.1016\/j.drugalcdep.2021.108666","article-title":"Navigating post-eviction drug use amidst a changing drug supply: a spatially-oriented qualitative study of overlapping housing and overdose crises in Vancouver, Canada.","volume":"222","author":"R McNeil","year":"2021","journal-title":"Drug and alcohol dependence"},{"key":"pone.0297567.ref104","doi-asserted-by":"crossref","DOI":"10.2307\/j.ctt1pwtdfw","volume-title":"Addicted to rehab: Race, gender, and drugs in the era of mass incarceration","author":"A. McKim","year":"2017"},{"key":"pone.0297567.ref105","author":"AC Bradford","year":"2022","journal-title":"Nuisance ordinances and overdose mortality"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0297567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T17:28:46Z","timestamp":1723656526000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0297567"}},"subtitle":[],"editor":[{"given":"Jennifer","family":"Tucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":105,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0297567","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]}}}